SAN FRANCISCO, October 30, 2018 /PRNewswire/ -- The global urothelial cancer drugs market size is expected to reach USD 3.6 billion by 2023, as per a new report by Grand View Research, Inc., exhibiting a 22.9% CAGR during the forecast period. Availability of novel drugs, presence of a...
from PR Newswire: //https://ift.tt/2yDEyJm
No comments:
Post a Comment